medigraphic.com
SPANISH

Revista Cubana de Pediatría

ISSN 1561-3119 (Electronic)
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2013, Number 2

<< Back Next >>

Rev Cubana Pediatr 2013; 85 (2)

First case of C1q nephropathy in Cuba

Campañá CNG, Chong LA, Durán ÁS, Hernández HS, Valdés MM
Full text How to cite this article

Language: Spanish
References: 14
Page: 258-264
PDF size: 236.03 Kb.


Key words:

nephrotic syndrome, C1q nephropathy, hematuria, proteinuria.

ABSTRACT

C1q nephropathy is a poorly understood glomerulopathy with some conceptual controversies, but with a distinctive immunologic characteristic (dominant or co-dominant deposit of C1q) and neither clinical nor serological evidence of systemic erythematous lupus. This is the case of a male patient who began suffering nephritic syndrome with hematuria, blood hypertension and renal failure at 10 months of age. A first renal biopsy was performed to detect diffuse mesangeal sclerosis; however after partial response of the patient to prednisone therapy and to maintenance treatment of proteinuria in nephritic range, with normalization of humoral parameters, then a second renal biopsy was performed with immunofluorescence. The final result was C1q nephropathy.


REFERENCES

  1. Jenette JC, Hipp CG. C1q Nephropathy: a distinct pathology entity usually causing nephrotic Syndrome. Am J Kidney Dis. 1985;6:103-10.

  2. Fogo AB. Minimal change disease and Focal Segmental Glomerulosclerosis. En: Fogo AB, Brujin JA, Cohen RB, Jenette JC. Fundamental of Renal Pathology. New York: Springer Science; 2006. p. 40-9.

  3. Focal Segmental Glomerulosclerosis. En: Non-neoplastic. Kidney diseases. King DW (Ed). Washington, DC.: Advisoy Board; 2005. p. 125-59.

  4. Nishida M, Kawakatsu H, Okumura Y, hamaoka K. C1q nephropathy with asymptomatic urine abnormalities. Pediatr Nephrol. 2005;20:1669-70.

  5. Srivastova T, Chaldha V, Taboada EM, Alon US. C1q nephropathy presenting as rapidly progressive crescentica glomerulonephritis. Pediatr Nephrol. 2000;14:976-9.

  6. Sardani Y, Qin K, Haas M, Aronson AJ, Rosenfield RL. Bartter syndrome complicated by immune complex nephropathy. Case report and literature review. Pediatr Nephrol. 2003;18:913-8.

  7. Roberti I, Baqi N, Vyas S, Kim DU. A single center study of C1q nephropathy in children. Pediatr Nephrol. 2009;24:77-82.

  8. Vizjak A, Ferluga D, Hvala A, Lindia J, Lervart TK, Jura V, et al. Pathology, presentations and outcomes of C1q Nephropaty. Am Soc Nephrol. 2008;11:2237-44.

  9. Taggart L, Harris A, El-Dart S, Iorember F. C1q Nephropathy in a child presenting with recurrent gross hematuria. Pediatr Nephrol. 2010;25:165-8.

  10. Maskowitz GS, Schwimmer JA, Barry Stokes M, Nasr S, Seigler RL, Valeri AM. C1q Nephropathy: a variant of focal segmental glomerulosclerosis. Kidney International. 2003;641:232-40.

  11. Lervat KT, Kenda RB, Cavié MA, Ferluga D, Hvala A, Vizjak A. C1q Nephropathy in children. Pediatr Nephrol. 2005;20:1756-61.

  12. Sharman A, Furness P, Feehally J. Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant. 2004;19:1420-6.

  13. Iskandar SS, Browning MC, Lorentz WB. C1q Nephropathy: A Pediatric Clinicopathology Study. Am J Kidney Dis. 1991;18:459-65.

  14. Hisano S, Fukuma Y, Segawa Y, Niimi K, Kaku Y, Hatoe K, el at. Clinicopathologic correlation and outcome of C1q nephropathy. J Am Soc Nephrol. 2008;6:1637-43.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Cubana Pediatr. 2013;85